However, there are no clear recommendations for regimens with a rest period (duration between two cytotoxic administrations, within one cycle or between two different cycles) of≤14 days. This study aimed to describe modalities of daily clinical use of biosimilar filgrastim in patients (pts) ...
Catalogue of Buprestidæcollected by the late M. Mouhot, in Siam, &c., with Descriptions of New Species]]>doi:10.1111/j.1365-2311.1967.tb01437.xEdwardSaundersWileyTransactions of the Royal Entomological Society of LondonOta, H., Fisher, R.N., Ineich, I., Case, T.J. (1995): ...